<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829357</url>
  </required_header>
  <id_info>
    <org_study_id>ESC_2020_04</org_study_id>
    <nct_id>NCT04829357</nct_id>
  </id_info>
  <brief_title>Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System</brief_title>
  <official_title>A Long Term Prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT ABBREVO® Continence System for the Treatment of Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this single arm, post market, clinical study is to evaluate the performance&#xD;
      of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for&#xD;
      Stress Urinary Incontinence (SUI).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2021</start_date>
  <completion_date type="Anticipated">February 27, 2033</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2032</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cough Stress Test (CST) Assessment Change</measure>
    <time_frame>Post-surgery through study completion, approximately 5-10 yrs</time_frame>
    <description>Objective cure of Stress Urinary Incontinence (SUI) (treatment success) approximately 5-10 years after surgery, defined as a negative CST</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Improvement (PGI-I)</measure>
    <time_frame>Post-surgery through study completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Consultation on Incontinence Questionnaire- Urinary Incontinence Short Form (ICIQ-UI SF)</measure>
    <time_frame>Baseline and post-surgery through study completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)</measure>
    <time_frame>Baseline and post-surgery through study completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wong-Baker FACES® Pain Rating Scale</measure>
    <time_frame>Post-surgery through study completion, approximately 10 yrs</time_frame>
    <description>To assess pain on a scale from 0 (no pain) to 10 (worst pain) related to study device or procedure.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">195</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention</intervention_name>
    <description>There is no intervention, beyond necessary clinical care, in this study. The surgical procedures being performed within the study are identical to the surgical procedures the subjects would receive as part of SOC.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female subjects ≥ 21 years of age with a diagnosis of SUI, resulting from urethral&#xD;
        hypermobility and/or intrinsic sphincter deficiency&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Subjects who satisfy all of the following criteria will be considered eligible for&#xD;
        enrollment in this study:&#xD;
&#xD;
          1. Stress urinary incontinence symptoms&#xD;
&#xD;
          2. Diagnostic evaluation, a positive cough stress rest, to confirm diagnosis of stress&#xD;
             urinary incontinence.&#xD;
&#xD;
          3. Female subjects ≥ 21 years of age requiring treatment of SUI&#xD;
&#xD;
          4. Desired surgical correction of stress urinary incontinence using synthetic&#xD;
             sub-urethral vaginal slings&#xD;
&#xD;
          5. Planned surgery for primary stress incontinence without concomitant prolapse surgery&#xD;
&#xD;
          6. Patient able and willing to participate in follow-up&#xD;
&#xD;
          7. Subject or authorized representative has signed the approved informed consent&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Subjects meeting any of the following criteria will be considered not eligible for&#xD;
        enrollment in this study:&#xD;
&#xD;
          1. Physical or psychological condition which would impair study participation or are&#xD;
             unwilling or unable to participate in all required study visits and are unable to&#xD;
             complete the questionnaires&#xD;
&#xD;
          2. Any pre-operative or intra-operative findings identified by the surgeon that may&#xD;
             preclude the use of study product&#xD;
&#xD;
          3. History of previous synthetic, biologic or fascial sub-urethral sling&#xD;
&#xD;
          4. Pregnancy or plans for future pregnancy&#xD;
&#xD;
          5. History of bleeding diathesis or current anti-coagulation therapy which cannot be&#xD;
             suspended peri-operatively according to site's standard practice.&#xD;
&#xD;
          6. Current genitourinary fistula or urethral diverticulum&#xD;
&#xD;
          7. Reversible cause of incontinence (i.e. drug effect)&#xD;
&#xD;
          8. Contraindication to surgery&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female subjects ≥ 21 years of age</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovannie A Tommaselli, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ethicon, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine Romanowski</last_name>
    <phone>908-218-3156</phone>
    <email>cromanow@its.jnj.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute for Female Pelvic Medicine</name>
      <address>
        <city>North Wales</city>
        <state>Pennsylvania</state>
        <zip>19454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>General University Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bio-Medical University Rome</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zelazna Medical Center</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale Regionale Beata Vergine</name>
      <address>
        <city>Mendrisio</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 12, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gynecare TVT ABBREVO® Continence System</keyword>
  <keyword>SUI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.</ipd_description>
    <ipd_url>http://yoda.yale.edu</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

